Article
Tissue biomarkers of immune checkpoint inhibitor therapy
16 Jan 2024
Abstract excerpt
Cancer immunotherapy has been rejuvenated by the growing understanding of the immune system's role in tumor activity over the past two decades. During cancer initiation and progression, tumor cells employ various mechanisms that resemble peripheral immune tolerance to evade the antitumor responses of the immune system. Immune checkpoint molecules are the major mechanism of immune resistance that are exploited by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
